{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T12:37:24Z","timestamp":1781354244075,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia Humanidades Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004881","name":"Mexican Social Security Institute","doi-asserted-by":"publisher","award":["R-2022-1305-041"],"award-info":[{"award-number":["R-2022-1305-041"]}],"id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.neuroscience.2025.12.025","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:33:17Z","timestamp":1765668797000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Monoacylglycerol lipase inhibition improves motor function and reduces oxidative stress in hemiparkinsonian mice"],"prefix":"10.1016","volume":"594","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7739-110X","authenticated-orcid":false,"given":"Delia Maciel","family":"Mendoza-Camacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Viveros-Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Eduardo","family":"Flores-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma Hortensia","family":"Mart\u00ednez-Preciado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0220-5523","authenticated-orcid":false,"given":"Aldo Rafael","family":"Tejeda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.025_b0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bpsc.2020.07.016","article-title":"Review of the Endocannabinoid System","volume":"6","author":"Lu","year":"2021","journal-title":"Biol. PsychiatryCognitive Neuroscience and Neuroimaging."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.025_b0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/EBC20190086","article-title":"The endocannabinoid system","volume":"64","author":"Kilaru","year":"2020","journal-title":"Essays Biochem."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0015","doi-asserted-by":"crossref","unstructured":"Mechoulam R, Parker LA. The Endocannabinoid System and the Brain. Annual Review of Psychology. 2013;64(Volume 64, 2013):21-47.","DOI":"10.1146\/annurev-psych-113011-143739"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/ars.2017.7144","article-title":"Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation","volume":"29","author":"Paloczi","year":"2017","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.025_b0025","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/mol.110.068304","article-title":"Monoacylglycerol Lipase Activity Is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System","volume":"78","author":"Chanda","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"19","key":"10.1016\/j.neuroscience.2025.12.025_b0030","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1039\/C4CS00047A","article-title":"Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids","volume":"43","author":"Kohnz","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0035","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-052220-021800","article-title":"Endocannabinoid-Based Therapies","volume":"62","author":"Piomelli","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0045","article-title":"Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson's Disease","volume":"2024","author":"Urmeneta-Ort\u00edz","year":"2024","journal-title":"Parkinsons Dis."},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2025.12.025_b0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0055","article-title":"Targeting Microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson's Disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134296","article-title":"Oxidative stress and Parkinson's disease: conflict of oxidant-antioxidant systems","volume":"709","author":"Hemmati-Dinarvand","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2020.101890","article-title":"Ferroptosis and its potential role in the physiopathology of Parkinson's Disease","volume":"196","author":"Mahoney-S\u00e1nchez","year":"2021","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.025_b0070","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.025_b0075","doi-asserted-by":"crossref","first-page":"e5310","DOI":"10.1002\/nbm.5310","article-title":"Altered Nigral Amide Proton Transfer Imaging Signal Concordant With Motor Asymmetry in Parkinson's Disease: A Multipool CEST MRI Study","volume":"38","author":"Tian","year":"2025","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0080","article-title":"Mitochondrial complex I deficiency and Parkinson disease","volume":"24(4):193-","author":"Drouin-Ouellet","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"issue":"10291","key":"10.1016\/j.neuroscience.2025.12.025_b0085","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.025_b0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease","volume":"15","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0095","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1038\/s41467-022-31168-9","article-title":"Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.12.025_b0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/0960327120984220","article-title":"JZL184 protects hippocampal neurons from oxygen-glucose deprivation-induced injury via activating Nrf2\/ARE signaling pathway","volume":"40","author":"Xu","year":"2020","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41531-025-00872-w","article-title":"Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson's disease mice","volume":"11","author":"Santoro","year":"2025","journal-title":"NPJ Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.12.025_b0110","doi-asserted-by":"crossref","first-page":"5715","DOI":"10.1007\/s12035-017-0752-7","article-title":"Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease","volume":"55","author":"Ryu","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.12.025_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123548","article-title":"The Neuroprotective Effects of the CB2 Agonist GW842166x in the 6-OHDA Mouse Model of Parkinson's Disease","volume":"10","author":"Yu","year":"2021","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0120","doi-asserted-by":"crossref","first-page":"20245","DOI":"10.1038\/s41598-023-47278-3","article-title":"Antinociceptive effect of intermittent fasting via the orexin pathway on formalin-induced acute pain in mice","volume":"13","author":"Shin","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0125","unstructured":"Franklin KBJ, Paxinos G. Paxinos and Franklin's The mouse brain in stereotaxic coordinates. Fourth edition. ed. Amsterdam: Academic Press, an imprint of Elsevier; 2013. 1 volume (unpaged) p."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnana.2014.00061","article-title":"Great insight created by tiny holes; celebrating 40 years of brain micropunch technique","volume":"8","author":"Agoston","year":"2014","journal-title":"Front. Neuroanat."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.12.025_b0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"6057","key":"10.1016\/j.neuroscience.2025.12.025_b0140","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.neuroscience.2025.12.025_b0145","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/bph.13215","article-title":"Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia","volume":"173","author":"Garcia","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.neuroscience.2025.12.025_b0155","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.neurobiolaging.2014.05.021","article-title":"Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model","volume":"35","author":"Fernandez-Suarez","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.025_b0160","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s10787-018-0470-4","article-title":"Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc","volume":"26","author":"Haddadi","year":"2018","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.025_b0165","first-page":"599","article-title":"Effects of quercetin on spatial memory, hippocampal antioxidant defense and BDNF concentration in a rat model of Parkinson's disease: An electrophysiological study","volume":"11","author":"Naghizadeh","year":"2021","journal-title":"Avicenna journal of phytomedicine."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.025_b0170","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.nbd.2008.11.011","article-title":"Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease","volume":"33","author":"Chen","year":"2009","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.12.025_b0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1134\/S1819712419040020","article-title":"Lipid Peroxidation Products in the Blood Plasma of Patients with Parkinson\u2019s Disease as Possible Biomarkers of Different Stages of the Disease","volume":"13","author":"Fedorova","year":"2019","journal-title":"Neurochem. J."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.12.025_b0180","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.chembiol.2009.05.009","article-title":"Characterization of monoacylglycerol lipase inhibition reveals differences in central and peripheral endocannabinoid metabolism","volume":"16","author":"Long","year":"2009","journal-title":"Chem. Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2023.07.019","article-title":"MAGL inhibition relieves synovial inflammation and pain via regulating NOX4-Nrf2 redox balance in osteoarthritis","volume":"208","author":"Li","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2015.07.024","article-title":"Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"273","author":"Mounsey","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0200","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/893516","article-title":"Anandamide protects HT22 cells exposed to hydrogen peroxide by inhibiting CB1 receptor-mediated type 2 NADPH oxidase","volume":"2014","author":"Jia","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.025_b0205","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1096\/fj.07-9411com","article-title":"Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury","volume":"22","author":"Choi","year":"2008","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.12.025_b0210","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/0960327120984220","article-title":"JZL184 protects hippocampal neurons from oxygen-glucose deprivation-induced injury via activating Nrf2\/ARE signaling pathway","volume":"40","author":"Xu","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"issue":"14","key":"10.1016\/j.neuroscience.2025.12.025_b0215","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1002\/jnr.21425","article-title":"PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity","volume":"85","author":"Carrasco","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.redox.2017.02.016","article-title":"NADPH oxidase-derived H(2)O(2) mediates the regulatory effects of microglia on astrogliosis in experimental models of Parkinson's disease","volume":"12","author":"Hou","year":"2017","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2131\/jts.38.25","article-title":"Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats","volume":"38","author":"Haleagrahara","year":"2013","journal-title":"J. Toxicol. Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.12.025_b0230","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s11064-012-0838-6","article-title":"Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase","volume":"37","author":"Iglesias-Gonz\u00e1lez","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ibneur.2023.11.007","article-title":"Superoxide dismutase and neurological disorders","volume":"16","author":"Chidambaram","year":"2024","journal-title":"IBRO Neuroscience Reports."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.025_b0240","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12640-023-00661-4","article-title":"Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal\/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors","volume":"41","author":"Paredes-Ruiz","year":"2023","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/836760","article-title":"SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration","volume":"2013","author":"Milani","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135534","article-title":"\u03b2-Caryophyllene exerts protective antioxidant effects through the activation of NQO1 in the MPTP model of Parkinson's disease","volume":"742","author":"Flores-Soto","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.12.025_b0255","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1002\/ctm2.447","article-title":"Inhibition of MAGL activates the Keap1\/Nrf2 pathway to attenuate glucocorticoid-induced osteonecrosis of the femoral head","volume":"11","author":"Yang","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.12.025_b0260","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.chembiol.2011.05.009","article-title":"Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer","volume":"18","author":"Nomura","year":"2011","journal-title":"Chem. Biol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.025_b0265","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1124\/mol.114.094284","article-title":"Robust hydrolysis of prostaglandin glycerol esters by human monoacylglycerol lipase (MAGL)","volume":"86","author":"Savinainen","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0270","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-030-21735-8_8","article-title":"Aspects of Prostaglandin Glycerol Ester Biology","volume":"1161","author":"Kingsley","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.12.025_b0275","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-1119(01)00559-5","article-title":"Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene","volume":"272","author":"Karlsson","year":"2001","journal-title":"Gene"},{"issue":"47","key":"10.1016\/j.neuroscience.2025.12.025_b0280","doi-asserted-by":"crossref","first-page":"44877","DOI":"10.1074\/jbc.M206788200","article-title":"Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides","volume":"277","author":"Kozak","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0285","article-title":"Endocannabinoid oxygenation by prostaglandin H synthase-2: chemistry and biology","volume":"110870","author":"Rouzer","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.neuroscience.2025.12.025_b0290","doi-asserted-by":"crossref","first-page":"37383","DOI":"10.1074\/jbc.M112.381202","article-title":"Prostaglandin H synthase-2-catalyzed oxygenation of 2-arachidonoylglycerol is more sensitive to peroxide tone than oxygenation of arachidonic acid","volume":"287","author":"Musee","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.neuroscience.2025.12.025_b0295","doi-asserted-by":"crossref","first-page":"30072","DOI":"10.1074\/jbc.M104467200","article-title":"Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid 2-arachidonylglycerol","volume":"276","author":"Kozak","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.12.025_b0300","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.bbalip.2019.01.009","article-title":"Prostaglandin D(2)-glycerol ester decreases carrageenan-induced inflammation and hyperalgesia in mice","volume":"1864","author":"Buisseret","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.12.025_b0305","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1096\/fj.201701205R","article-title":"The endogenous bioactive lipid prostaglandin D(2)-glycerol ester reduces murine colitis via DP1 and PPARgamma receptors","volume":"32","author":"Alhouayek","year":"2018","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.12.025_b0310","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/mol.110.070441","article-title":"15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma","volume":"80","author":"Raman","year":"2011","journal-title":"Mol. Pharmacol."},{"issue":"26","key":"10.1016\/j.neuroscience.2025.12.025_b0315","doi-asserted-by":"crossref","first-page":"23278","DOI":"10.1074\/jbc.M201084200","article-title":"15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist","volume":"277","author":"Kozak","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.12.025_b0320","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1007\/s12035-021-02400-2","article-title":"Inhibition of 2-Arachidonoylglycerol Metabolism Alleviates Neuropathology and Improves Cognitive Function in a Tau Mouse Model of Alzheimer's Disease","volume":"58","author":"Hashem","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.12.025_b0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2012.03.010","article-title":"Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression","volume":"246","author":"Sadeghian","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuroscience.2025.12.025_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105222","article-title":"Pioglitazone transiently stimulates paraoxonase-2 expression in male nonhuman primate brain: Implications for sex-specific therapeutics in neurodegenerative disorders","volume":"152","author":"Blackburn","year":"2022","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.12.025_b0335","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/ars.2010.3430","article-title":"Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis","volume":"14","author":"Devarajan","year":"2011","journal-title":"Antioxid. Redox Signal."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225011728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225011728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T10:22:26Z","timestamp":1773915746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225011728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":67,"alternative-id":["S0306452225011728"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.12.025","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoacylglycerol lipase inhibition improves motor function and reduces oxidative stress in hemiparkinsonian mice","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}